Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic menTrevor A. Mori, Lawrence J. Beilin, Valerie Burke et al.|American Journal of Clinical Nutrition|2000Cited by 586
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDavid M. Maahs, John W. Lum, Bruce A. Buckingham et al.|Diabetes Care|2016Cited by 215
SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital AdmissionPeter S. Hamblin, Leon A. Bach, Rosemary Wong et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 122